Home Latest Articles
Latest Articles
  • Wen-liang JIANG
    World Clinical Drug. 2018, 39(12): 864-864.

    As a biological targeting drug used for childhood-onset systemic lupus erythematosus (cSLE) treatment, the rituximab is an important drug, which can improve the prognosis of cSLE through depleting B cells. This review describes the clinical characteristics of cSLE and its treatment applied with rituximab, to provide a reference for clinical practice.

  • Rong CHEN, Hong-zhou LU
    World Clinical Drug. 2018, 39(11): 721-726.

    The clinical practice guideline for the chronic pain management in the patients living with HIV (PLWH) were released by the HIV Medicine Association (HIVMA), Infectious Diseases Society of America (IDSA) in October 2017. In this guideline, the types and manifestations of chronic pain among PLWH are described. Furthermore, the 51 evidence-based medicine recommendations are put forward from 13 aspects, including chronic pain screening, evaluation, drug and non-drug treatment, and the management of chronic pain in special populations. This paper provides the guideline interpretation and emphasizes the principle management for chronic pain in the PLWH.

  • Tang-kai QI, Hong-zhou LU
    World Clinical Drug. 2018, 39(11): 727-731.

    Human immunodeficiency virus (HIV) is the virus, which attacks body's immune system. It can make the infected person to lose immune function and easily infect all kinds of diseases. HIV may produce malignant tumors, which seriously threatens human life and health. The pre-exposure prophylaxis (PrEP) and non-occupational postexposure prophylaxis (nPEP) are two important strategies to prevent HIV infection. At 2017, The Canadian HIV clinical trial network updated the Canadian guideline on HIV PrEP and nPEP. This article gives a brief interpretation of this guideline to provide a reference for domestic clinical physicians.

  • Jing-na XUN, Hong-zhou LU
    World Clinical Drug. 2018, 39(11): 732-736.

    Acquired immunodeficiency syndrome (AIDS) is the infectious disease caused by human immunodeficiency virus (HIV). The main challenge in eradicating is the existence of HIV reservoir. Recent advances in HIV studies mainly include the identification of more sorts of reservoir cells, and more understanding of the characteristics of the viral reservoirs in different tissues. Research on eliminating the reservoir includes: the shock and kill strategy, the stem cell transplantation therapy and the gene therapy, as well as inducing specific immunity against HIV. This article provides a brief overview of the progress in these areas above.

  • Xiao-qing HE, Yin-zhong SHEN
    World Clinical Drug. 2018, 39(11): 737-742.

    With the widespread use of antiretroviral therapy (ART) in clinical practice and the prolongation of the survival time of the people infected with human immunodeficiency virus (HIV), the incidence of coronary artery disease (CAD) in acquired immunodeficiency syndrome (AIDS) patients has been increased significantly. At present, CAD has become one of the main factors, which affects the prognosis and life quality of AIDS patients. Therefore, it is very significant to understand the relationship between HIV infection and CAD for clinical practice. This review summarizes the prevalence and clinical characteristics of CAD in AIDS patients, and its related diagnosis and treatment.

  • Qi ZHANG, Jing-wen XU, Yi-qing WANG, Xiao-nian QIAN, Dong-feng SHI
    World Clinical Drug. 2018, 39(11): 743-748.
    Objective

    To investigate and analyze the effect of olanzapine on the lipids and immune indexes of IGF2BP2, SLC30A8 gene polymorphism in schizophrenia patients.

    Methods

    A total of 105 schizophrenic patients, who stayed in our hospital from September 2017 to April 2018, were collected as observation group, and other 100 healthy subjects were selected as control group. The observation group was given olanzapine orally. The IGF2BP2 and SLC30A8 genotyping in both observation group and control group were performed. The blood lipid biochemical indexes and immune indexes of observation group were observed and compared before treatment and 6 months after treatment, and the clinical efficacy was calculated.

    Results

    There were the TT, TC and CC 3 genotypes in rs1326634 of SLC30A8, and the TT, TG and GG genotypes in rs4402960 of IGF2BP2. The genotypes of SLC30A8 in 2 groups were not significant difference (P>0.05). Compared with control group, the cases of TT genotypes in IGF2BP2 in observation group was more (P<0.05). Compared with before treatment, the cholesterol (CHOL) and low density lipoprotein cholesterol (LDL-C) of each genotype were significantly increased (P<0.05), and the high density lipoprotein cholesterol (HDL-C) was significantly lower (P<0.05). Compared with before treatment, the triglyceride (TRIG), CHOL and LDL-C of all genotypes were increased, and the HDL-C was decreased. Compared with before treatment, the TT and GG-type's LDL were increased significantly (P<0.05), the TG and GG type's CHOL were increased significantly (P<0.05), the GG-type's HDL-C was decreased significantly after treatment (P<0.05). Compared with before treatment, the CD+3, CD+8 and CD+4/CD+8 of all genotypes were increased after treatment.

    Conclusions

    The IGF2BP2 is a susceptible gene for schizophrenia. Olanzapine can improve the clinical symptoms and immune parameters of schizophrenia patients. However, the IGF2BP2 gene polymorphism may leads to olanzapine tolerance, dyslipidemia and poor efficacy.

  • Shu PAN, Yong-fang YUAN, Jian JIN
    World Clinical Drug. 2018, 39(11): 749-755.
    Objective

    To evaluate the efficacy and safety of oral corticosteroids in the treatment of acute gout.

    Methods

    Through the computer searches from the data base: CNKI, VIP, Wanfang Database, China Biomedical Literature Database, PubMed, EMBase, Medline and Cochrane Library, the acute gout patients, were randomly divided into trial group (oral glucocorticoids) and control group (oral colchicine or non-steroidal anti-inflammatory drugs). The results of clinical study, which meets the inclusion criteria, were evaluated. A comprehensive search of databases in both Chinese and English was performed. Data from the selected studies were extracted and analyzed independently. RevMan 5.3 software was conducted for Meta-analysis.

    Results

    Meta-analysis results showed that the total effective rate of trial group was equal to control group [OR=1.00, 95%CI (0.70, 1.42), P>0.05)]. The onset time [MD=-3.96, 95%CI (-4.16, -3.75), P<0.000 01)], anti-inflammatory action [MD=-4.66, 95%CI (-5.13, -4.20), P<0.000 01)][MD=-9.47, 95%CI (-10.47, -8.48), P<0.000 01)] and AEs [OR=0.38, 95%CI (0.27, 0.53), P<0.000 01)] in trial group were significantly higher than those of control group.

    Conclusion

    Oral corticosteroids have good efficacy and a safer strategy for acute gout treatment.

  • Yun-qian ZHU, Zhen LIU, Wen-xuan LI, Xiao-ming WANG
    World Clinical Drug. 2018, 39(11): 756-759.
    Objective

    To initially establish the reference range of coagulation function indicators in healthy premature infants in Shanghai local.

    Methods

    Total of 134 neonatal cases admitted to the pediatric neonatal unit of the Fifth People's Hospital of Shanghai, from January 2015 to January 2017, were collected. Among them 107 were healthy premature infants as premature infant group, and 27 were term infants as term infant group. The coagulation parameters between the two groups were compared. The indexes of activation part prothrombin time (APTT), prothrombin time (PT), thrombin time (TT), and fibrinogen (FIB) in premature infant group were analyzed.

    Results

    According to the inclusion and exclusion criteria, the birth weights of the two groups were significantly different [(2.14±0.42) kg vs (3.45±0.34)kg](P<0.05). However, there was no statistical difference in gender composition, mode of delivery, one-minute and five-minute Apgar score (P>0.05). The APTT and PT time in premature infant group were longer than those in term infant group [(58.90±20.40)s, (15.30±2.30)s vs (40.20±16.40)s, (12.80±2.10)s](P<0.05, P<0.01), and there was no statistical difference in TT and FIB (P>0.05). A 95% CI for coagulation function test in premature infant group was APTT (18.92~98.88) s, PT (11.00~19.80) s, TT (17.30~29.20) s, FIB (0.87~4.05) g/L.

    Conclusion

    The PT and APTT of healthy premature infants are longer than those of term infants. To establish the reference range of coagulation function indicators for healthy premature infants can obtain a better guide for clinical diagnosis and treatment.

  • Chong YUE, Qiang JIA
    World Clinical Drug. 2018, 39(11): 760-763.
    Objective

    To observe the effect of serum albumin (ALB) level on the coagulation function in primary nephrotic syndrome patients.

    Methods

    A total of 61 adult patients with primary nephrotic syndrome were selected and divided into group A and group B according to their ALB<20 g/L and ALB≥20 g/L. The patients' whole blood platelet count (PLT), mean platelet volume (MPV), and platelet distribution width (PDW), plasma prothrombin time (PT), activated partial thrombin time (APTT), plasma fibrinogen (FIB) and D-Dimer (DD) were analyzed. The related factors of serum ALB level in two groups were compared.

    Results

    The MPV, PCT, PDW, APTT and PT in two groups had no statistical difference (P>0.05). The patients’ PLT, FIB and DD in group A were higher than those in group B, the FIB was negatively correlated with ALB (r=-0.778, P=0.000 1), the PLT is negatively correlated with ALB (r=-0.292,P=0.023).

    Conclusion

    The patients with primary nephrotic syndrome have different coagulation function as the change in serum ALB level.

  • Qiong WANG, Yi-qun LING, Hui-ping DING, Yan WU, Yong QIAN, Bing-qin HE
    World Clinical Drug. 2018, 39(11): 764-768.
    Objective

    To observe the preoperative nutritional status of surgical hepatic carcinoma patients, and analyze the relationship between malnutrition and human body composition.

    Methods

    The data of 85 preoperative hepatic carcinoma patients, which collected in Fudan university Shanghai cancer center from September to October 2016, were analyzed by patient-generated subjective global assessment (PG-SGA) and body composition.

    Results

    For 85 patients, the PG-SGA average score is (3.86±3.56) points. There were 53 cases with well nutrition (0~3 points), 32 cases with malnutrition (≥4 points), and the incidence rate of malnutrition was 37.6%. And for the malnutrished group patients, their total body moisture, intracellular moisture, extracellular moisture, protein, inorganic salt, fat free mass, skeletal muscle, muscle mass, body cell, and bone mineral content were significantly lower than those of well nourished group patients; the difference was statistically significant (P<0.01). However, there was no statistically significant difference in body mass index and body fat mass between the two groups (P>0.05). The correlation between PG-SGA score and body composition showed that the PG-SGA score was negatively correlated with total body moisture, intracellular water, extracellular water, protein, inorganic salt, muscle mass, fat free mass, skeletal muscle, body cell and bone mineral content (P<0.05, P<0.01). Further analysis showed that the PG-SGA score of elderly patients and male patients was negatively correlated with total body moisture, intracellular water, extracellular moisture, protein, inorganic salt, fat free mass, skeletal muscle, muscle mass, body cell and bone mineral content (P<0.05, P<0.01), while the PG-SGA score of non-elderly patients and female patients was not correlated with human components.

    Conclusions

    PG-SGA is a good tool for the preoperative nutritional assessment of hepatic carcinoma patients, which can provide a basis for postoperative reasonable nutrition support before patients' surgery.

News